Alemtuzumab for Multiples Sclerosis: Who and When to treat?Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Risk of Myocardial Infarction and Stroke after Acute Infection or VaccinationNEJM 351:2611-2618, Smeeth,L.,et al, 2004